Is Mesa Laboratories, Inc. (MLAB) a Buy, Sell, or Hold?
NASDAQ : MLAB
Mesa Laboratories, Inc.
$97.94 USD
-$1.5 (-1.51%)
- Volume
- 188.72K
- Average Volume
- 195.4K
- Market Capitalization
- $541.11M
- P/E Ratio
- 79.63
- Dividend Yield
- 0.65%
- Price Target
- $94.00
- Year High
- $113.99
- Year Low
- $55.45
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.52
- Current Ratio
- $1.72
Company Overview
NASDAQ
Siddhartha C. Kadia
Medical - Equipment & Services
Healthcare
MLAB
717
US
USD
Liquidity Metrics
0.83
1.72
1.29
0.44
0.52
Sales & Valuation
$249.13M
2.17
2.92
12.63
7.73
Profitability
$1.21
$6.71M
2.69%
4.82%
3.71%
1.57%
P/E Metrics
79.63
-0.11
-0.11
Analyst Price Target & Rating
$94.00
$94.00
$94.00
3/5
8 Analysts
4.19%
Poll Results
About Mesa Laboratories, Inc. (NASDAQ:MLAB) Stock
Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides testing and laboratory services to the dental and pharmaceutical industries. Its Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for inherit ... ed genetic disease testing, pharmacogenetics, oncology testing, infectious disease testing, doping and toxicology testing, and other differentiated applications for use in research. The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; PurePep Chorus and Symphony instruments for peptide synthesis; and PurePep EasyClean products for purifying peptides. Its Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as environmental and process monitoring, dialysis, gas flow, air quality, and torque testing in medical device and pharmaceutical manufacturing, laboratory, and hospital environments. This segment’s products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems under DialyGuard, ViewPoint, DataTrace, DryCal, and BGI brands. Mesa Laboratories, Inc. was incorporated in 1982 and is headquartered in Lakewood, Colorado.
MESA LABS DECLARES QUARTERLY DIVIDEND
2026-07-06 09:50:00
Lakewood, Colo., July 06, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on September 15, 2026, to shareholders of record at the close of business on August 31, 2026.
Why Mesa Laboratories Stock Is Getting Hit With a Huge Sell-Off Today
2026-05-27 15:36:19
Mesa Laboratories fell after reporting its Q4 fiscal 2026 results. Sales and earnings came in below Wall Street's expected earnings, but the business did report strong growth for adjusted operating income.
Mesa Labs Announces Fourth Quarter and Fiscal Year 2026 Results
2026-05-27 08:00:00
LAKEWOOD, Colo., May 27, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (“Mesa” or “the Company”), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced results for its fourth fiscal quarter (“4Q26”) and fiscal year (“FY26”) ended March 31, 2026 (amounts in thousands).
Mesa Laboratories, Inc. to Announce Fourth Quarter and Full Fiscal Year Results on May 27, 2026
2026-05-05 13:39:00
LAKEWOOD, Colo., May 05, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) will issue a press release with financial results for the fourth quarter and the fiscal year ended March 31, 2026 at approximately 6:00 A.M. Eastern Time (ET) on Wednesday, May 27, 2026.
Frequently Asked Questions
-
What is the current Mesa Laboratories, Inc. (MLAB) stock price?
-
Mesa Laboratories, Inc.(NASDAQ:MLAB) stock price is $97.94 in the last trading session. During the trading session, MLAB stock reached the peak price of $113.99 while $55.45 was the lowest point it dropped to. The percentage change in MLAB stock occurred in the recent session was --1.51% while the dollar amount for the price change in MLAB stock was -$1.5.
-
MLAB's industry and sector of operation?
-
The NASDAQ listed MLAB is part of Medical - Equipment & Services industry that operates in the broader Healthcare sector.
-
Who are the executives of MLAB?
-
Siddhartha Chandrakant Kadia | Chief Executive Officer, President & Director
Brian David Archbold | Senior Vice President of Continuous Improvement
Lyndsey Crennen | Chief Accounting Officer
John V. Sakys | VP & CFO
| -
How many employees does MLAB have?
-
Number of MLAB employees currently stands at 717. MLAB operates from 12100 West Sixth Avenue, Lakewood, CO 80228, US.
-
Link for MLAB official website?
-
Official Website of MLAB is: https://www.mesalabs.com
-
How do I contact MLAB?
-
MLAB could be contacted at phone #303 987 8000 and can also be accessed through its website. MLAB operates from 12100 West Sixth Avenue, Lakewood, CO 80228, US.
-
How many shares of MLAB are traded daily?
-
The average number of MLAB shares traded daily for last 3 months was 195.4K.
-
What is the market cap of MLAB currently?
-
The market value of MLAB currently stands at $541.11M with its latest stock price at $97.94